TNX-102 SL* for the Treatment of Fibromyalgia: Role of Nonrestorative Sleep on Pain Centralization

Poster Presentation at the European Union League Against Rheumatism (EULAR) 2015 Annual Meeting in Rome, IT

Lederman S, Clauw D, Gendreau JF, Arnold L, Moldofsky H, Mease P, Daugherty BL, Gendreau RM. THU0325 TNX-102 SL for the Treatment of Fibromyalgia: Role of Nonrestorative Sleep on Pain Centralization. Ann Rheum Dis. 2015; 74(Suppl 2): 313.

TNX-102 SL* for Treatment of Fibromyalgia: Approaches to Pain Measurement

Poster Presentation at the European Union League Against Rheumatism (EULAR) 2015 Annual Meeting in Rome, IT

Gendreau RM, Clauw D, Gendreau JF, Daugherty BL, Lederman S. THU0322 TNX-102 SL for Treatment of Fibromyalgia: Approaches to Pain Measurement. Ann Rheum Dis. 2015; 74(Suppl 2): 312.

Serotonin Receptor Profiles of Bedtime Pharmacotherapies Targeting Posttraumatic Stress Disorder (PTSD)

Poster Presentation at the Society of Biological Psychiatry 2015 Annual Meeting in Toronto, CA

Daugherty B, Sullivan G, Gershell L, Lederman S. 728. Serotonin Receptor Profiles of Bedtime Pharmacotherapies Targeting Posttraumatic Stress Disorder (PTSD). Biological Psychiatry. 2015; 77(Suppl 1): 271S-272S.

Cyclobenzaprine (CBP) and its Major Metabolite Norcyclobenzaprine (nCBP) are Potent Antagonists of the Serotonin Receptor 2A, Histamine H1 and α-Adrenergic Receptors: Mechanistic and Safety Implications...

Poster Presention in November 2013 at the American College of Rheumatology Annual Meeting.

Bruce Daugherty, PhD; Leland Gershell, MD, PhD; Seth Lederman, MD